In the early nineties, Dick and colleagues observed that most subtypes of acute myeloid leukemia (AML) could be engrafted reliably in immunodeficient mice and that leukemic engraftment could only be initiated from CD34+CD38− fractions. Here, CD34 is linked to acute myeloid leukemia.